These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

234 related items for PubMed ID: 16946457

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Update of the drug resistance mutations in HIV-1: Fall 2005.
    Johnson VA, Brun-Vezinet F, Clotet B, Conway B, Kuritzkes DR, Pillay D, Schapiro JM, Telenti A, Richman DD.
    Top HIV Med; 2005; 13(4):125-31. PubMed ID: 16304457
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Update of the Drug Resistance Mutations in HIV-1.
    Johnson VA, Brun-Vezinet F, Clotet B, Gunthard HF, Kuritzkes DR, Pillay D, Schapiro JM, Richman DD.
    Top HIV Med; 2008 Dec; 16(5):138-45. PubMed ID: 19106428
    [Abstract] [Full Text] [Related]

  • 5. Drug resistance mutations in HIV-1.
    Johnson VA, Brun-Vézinet F, Clotet B, Conway B, D'Aquila RT, Demeter LM, Kuritzkes DR, Pillay D, Schapiro JM, Telenti A, Richman DD, International AIDS Society-USA Drug Resistance Mutations Group.
    Top HIV Med; 2003 Dec; 11(6):215-21. PubMed ID: 14724329
    [Abstract] [Full Text] [Related]

  • 6. Primary drug resistance in antiretroviral-naïve injection drug users.
    Tossonian HK, Raffa JD, Grebely J, Viljoen M, Mead A, Khara M, McLean M, Krishnamurthy A, DeVlaming S, Conway B.
    Int J Infect Dis; 2009 Sep; 13(5):577-83. PubMed ID: 19111493
    [Abstract] [Full Text] [Related]

  • 7. Prevalence of resistance-associated mutations in newly diagnosed HIV-1 patients in Greece.
    Paraskevis D, Magiorkinis E, Katsoulidou A, Hatzitheodorou E, Antoniadou A, Papadopoulos A, Poulakou G, Paparizos V, Botsi C, Stavrianeas N, Lelekis M, Chini M, Gargalianos P, Magafas N, Lazanas M, Chryssos G, Petrikkos G, Panos G, Kordossis T, Theodoridou M, Sypsa V, Hatzakis A, Hellenic Multi-centre study on HIV-resistance.
    Virus Res; 2005 Sep; 112(1-2):115-22. PubMed ID: 16022906
    [Abstract] [Full Text] [Related]

  • 8. HIV-1-resistant strains during 8-week on 8-week off intermittent therapy and their effect on CD4+ T-cell counts and antiviral response.
    Izopet J, Marchou B, Charreau I, Sauné K, Tangre P, Molina JM, Aboulker JP, Window (ANRS 106) Study Team.
    Antivir Ther; 2008 Sep; 13(4):537-45. PubMed ID: 18672532
    [Abstract] [Full Text] [Related]

  • 9. [Research on the selective kinetics of HIV-1 nucleoside reverse transcriptase inhibitor drug resistance-associated mutations among 4 AIDS patients receiving highly active antiretroviral therapy].
    Li J, Jiao LY, Li HP, Li L, Liu YJ, Zhuang DM, Liu SY, Bao ZY, Li H, Wang Z, Li JY.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Aug; 29(8):794-800. PubMed ID: 19103117
    [Abstract] [Full Text] [Related]

  • 10. Profile of drug resistance mutations among HIV-1-infected Tunisian subjects failing antiretroviral therapy.
    Jlizi A, Ben Ammar El Gaaied A, Slim A, Tebourski F, Ben Mamou M, Ben Chaabane T, Letaief-Omezzine A, Chakroun M, Garbouj M, Ben Rejeb S.
    Arch Virol; 2008 Aug; 153(6):1103-8. PubMed ID: 18483694
    [Abstract] [Full Text] [Related]

  • 11. Antiretroviral combinations implicated in emergence of the L74I and L74V resistance mutations in HIV-1-infected patients.
    Wirden M, Lambert-Niclot S, Marcelin AG, Schneider L, Ait-Mohand H, Brunet C, Angleraud F, Amard S, Katlama C, Calvez V.
    AIDS; 2009 Jan 02; 23(1):95-9. PubMed ID: 19050391
    [Abstract] [Full Text] [Related]

  • 12. [Basic approaches to anti-HIV resistance].
    Baba M.
    Nihon Rinsho; 2002 Apr 02; 60(4):763-8. PubMed ID: 11968785
    [Abstract] [Full Text] [Related]

  • 13. The impacts of current antiretroviral therapy regimens on Chinese AIDS patients and their implications for HIV-1 drug resistance mutation.
    Zhang M, Han XX, Cui WG, Jia MH, Meng XD, Xing AH, Wu YH, Yang YY, Lu CM, Hu QH, Dai D, Zhang ZN, Shang H.
    Jpn J Infect Dis; 2008 Sep 02; 61(5):361-5. PubMed ID: 18806342
    [Abstract] [Full Text] [Related]

  • 14. HIV-1 pol phylogenetic diversity and antiretroviral resistance mutations in treatment naïve patients from Central West Brazil.
    Cardoso LP, Queiroz BB, Stefani MM.
    J Clin Virol; 2009 Oct 02; 46(2):134-9. PubMed ID: 19682948
    [Abstract] [Full Text] [Related]

  • 15. Antiretroviral drug resistance testing in adult HIV-1 infection: 2008 recommendations of an International AIDS Society-USA panel.
    Hirsch MS, Günthard HF, Schapiro JM, Brun-Vézinet F, Clotet B, Hammer SM, Johnson VA, Kuritzkes DR, Mellors JW, Pillay D, Yeni PG, Jacobsen DM, Richman DD.
    Clin Infect Dis; 2008 Jul 15; 47(2):266-85. PubMed ID: 18549313
    [Abstract] [Full Text] [Related]

  • 16. Identification of alternative amino acid substitutions in drug-resistant variants of the HIV-1 reverse transcriptase.
    Berkhout B, Back NK, de Ronde A, Jurriaans S, Bakker M, Parkin NT, van der Hoek L.
    AIDS; 2006 Jul 13; 20(11):1515-20. PubMed ID: 16847406
    [Abstract] [Full Text] [Related]

  • 17. Novel drug resistance mutations in HIV: recognition and clinical relevance.
    Perno CF, Svicher V, Ceccherini-Silberstein F.
    AIDS Rev; 2006 Jul 13; 8(4):179-90. PubMed ID: 17219733
    [Abstract] [Full Text] [Related]

  • 18. Compilation and prevalence of mutations associated with resistance to non-nucleoside reverse transcriptase inhibitors.
    Tambuyzer L, Azijn H, Rimsky LT, Vingerhoets J, Lecocq P, Kraus G, Picchio G, de Béthune MP.
    Antivir Ther; 2009 Jul 13; 14(1):103-9. PubMed ID: 19320243
    [Abstract] [Full Text] [Related]

  • 19. 2019 update of the drug resistance mutations in HIV-1.
    Wensing AM, Calvez V, Ceccherini-Silberstein F, Charpentier C, Günthard HF, Paredes R, Shafer RW, Richman DD.
    Top Antivir Med; 2019 Sep 13; 27(3):111-121. PubMed ID: 31634862
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.